HBV 1.3-mer P-null replicon Citations (5)

Originally described in: DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids.
Wang H, Kim S, Ryu WS J Virol. 2009 Jun;83(11):5815-24. doi: 10.1128/JVI.00011-09. Epub 2009 Mar 18. PubMed Journal

---

Articles Citing HBV 1.3-mer P-null replicon

Articles
Tripartite motif protein 52 (TRIM52) promoted fibrosis in LX-2 cells through PPM1A-mediated Smad2/3 pathway. Zhou J, Lan Q, Li W, Yang L, You J, Zhang YM, Ni W. Cell Biol Int. 2019 Jul 22. doi: 10.1002/cbin.11206. PubMed
HBV-Pol is crucial for HBV-mediated inhibition of inflammasome activation and IL-1beta production. Lei Q, Li T, Kong L, Li L, Ding X, Wang X, Zhang X, Qin B. Liver Int. 2019 Dec;39(12):2273-2284. doi: 10.1111/liv.14214. Epub 2019 Aug 30. PubMed
ROS/NF-kappaB Signaling Pathway-Mediated Transcriptional Activation of TRIM37 Promotes HBV-Associated Hepatic Fibrosis. Xie H, Xie D, Zhang J, Jin W, Li Y, Yao J, Pan Z, Xie D. Mol Ther Nucleic Acids. 2020 Aug 19;22:114-123. doi: 10.1016/j.omtn.2020.08.014. PubMed
Hepatitis B virus X protein recruits methyltransferases to affect cotranscriptional N6-methyladenosine modification of viral/host RNAs. Kim GW, Siddiqui A. Proc Natl Acad Sci U S A. 2021 Jan 19;118(3). pii: 2019455118. doi: 10.1073/pnas.2019455118. PubMed
HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma. Turnham RE, Pitea A, Jang GM, Xu Z, Lim HC, Choi AL, Von Dollen J, Levin RS, Webber JT, McCarthy E, Hu J, Li X, Che L, Singh A, Yoon A, Chan GKL, Kelley RK, Swaney DL, Zhang W, Bandyopadhyay S, Theis FJ, Eckhardt M, Chen X, Shokat KM, Ideker T, Krogan NJ, Gordan JD. Cancer Res. 2025 Feb 17;85(4):660-674. doi: 10.1158/0008-5472.CAN-24-0456. PubMed

If you have published an article using this material, please email us at to have your article added to this page.